Could RO7851624, newly into clinical trials, be RG6735?
ApexOnco Front Page
Recent articles
The company sidelines CDK2 and pan-KRAS blockers, among other projects.
The CD70-targeting CTX131 heads for the scrapheap.
Harmoni-A hits, backing a quiet disclosure about the Harmoni trial.
BG-75202 features among several projects starting first-in-human trials.
Inhibrx reveals three deaths in phase 1, but all predate screening protocols.
There will soon be three PD-(L)1 x VEGF projects in pivotal lung and colorectal cancer trials.
The Fortitude-102 trial, testing a bemarituzumab/Opdivo/chemo triplet, has failed.
